Patents Assigned to TOT SHANGHAI R&D CENTER CO., LTD.
  • Mutant vaccinia virus strains, uses thereof and method of producing the same
    Patent number: 9765305
    Abstract: The present disclosure provides mutant vaccinia virus strains that can selectively replicate in tumor cells. The present disclosure also provides use of the mutant vaccinia virus strains for preventing and treating tumors.
    Type: Grant
    Filed: September 23, 2015
    Date of Patent: September 19, 2017
    Assignee: TOT SHANGHAI R&D CENTER CO., LTD.
    Inventors: Li Qin, Min Liang, David H. Evans
  • RECOMBINANT TUMOR VACCINE AND METHOD OF PRODUCING SUCH VACCINE
    Publication number: 20130108665
    Abstract: The present disclosure provides tumor vaccines useful for preventing and treating tumors and cancers. The tumor vaccines may contain nucleic acids encoding for antigen presenting peptides, cytokines and other factors useful for preventing and treating tumors and cancers, or expression vectors or viruses containing such nucleic acids, or host cells containing such nucleic acids or expression vectors.
    Type: Application
    Filed: June 30, 2011
    Publication date: May 2, 2013
    Applicant: TOT SHANGHAI R&D CENTER CO., LTD.
    Inventor: Min Liang